 |
InterPro: IPR000759 Adrenodoxin reductase
Protein matches
|
UniProtKB Matches: 3962 proteins |
|
Accession
|
IPR000759 Adrndx_reductase |
Type
|
Domain |
Signatures
|
|
InterPro Relationships
|
|
Found in
|
IPR006004 Glutamate synthase (NADPH), homotetrameric
IPR006005 Glutamate synthase, NADH/NADPH, small subunit 1
IPR006006 Glutamate synthase, NADH/NADPH, small subunit 2
IPR012142 Tryptophan 2-monooxygenase
IPR012220 Glutamate synthase, eukaryotic
IPR013027 FAD-dependent pyridine nucleotide-disulphide oxidoreductase
IPR014103 Carotene 7,8-desaturase
IPR017701 Putative selenate reductase YgfK
|
|
InterPro annotation
|
|
Entry Details in BioMart
|
Abstract
|
Mitochondrial P450-containing systems comprise 3 components, an FAD-containing flavoprotein
NADPH:adrenodoxin reductase (AR); an iron-sulphur protein, adrenodoxin; and P450 [1].
The direction of electron flow is NADPH to AR to adrenodoxin to P450. FAD can be reduced by 2
electrons from NADPH, which are transferred one at a time to adrenodoxin, a one-electron carrier.
Both AR and adrenodoxin are soluble proteins located on the matrix side of the inner mitochondrial
membrane. Despite functional parallels, AR shows no global similarity either to flavoprotein
pyridine nucleotide cytochrome reductases (FPNCR) or to FAD-dependent pyridine nucleotide
reductases (FADPNR) [2]. However, BLAST searches reveal local similarity of the
N-terminal region of AR to glutamate synthase and NADH peroxidase, especially in the nucleotide-binding regions, suggesting that AR and FADPNR may be distantly related.
|
Structural links
|
|
Database links
|
|
Example proteins
|
P22570 NADPH:adrenodoxin oxidoreductase, mitochondrial
P48360 Probable NADPH:adrenodoxin oxidoreductase, mitochondrial
Q18164 Dihydropyrimidine dehydrogenase [NADP+]
Q61578 NADPH:adrenodoxin oxidoreductase, mitochondrial
Q9V3T9 NADPH:adrenodoxin oxidoreductase, mitochondrial
More proteins
Example Proteins Key
| InterPro entry accession number/name and structure databases |
Colour code |
| IPR013785 |
Aldolase-type TIM barrel |
 |
| IPR009051 |
Alpha-helical ferredoxin |
 |
| IPR017896 |
4Fe-4S ferredoxin, iron-sulpur binding domain |
 |
| IPR012285 |
Fumarate reductase, C-terminal |
 |
| IPR001450 |
4Fe-4S ferredoxin, iron-sulphur binding, subgroup |
 |
| IPR017900 |
4Fe-4S ferredoxin, iron-sulphur binding, conserved site |
 |
| IPR016040 |
NAD(P)-binding domain |
 |
| IPR012135 |
Dihydroorotate dehydrogenase, class 1/ 2 |
 |
| IPR005720 |
Dihydroorotate dehydrogenase, class 1, core |
 |
| IPR013027 |
FAD-dependent pyridine nucleotide-disulphide oxidoreductase |
 |
| IPR000759 |
Adrenodoxin reductase |
 |
| IPR001327 |
Pyridine nucleotide-disulphide oxidoreductase, NAD-binding region |
 |
|
ModBase |
 |
|
SWISS-MODEL |
 |
|
Additional Reading
|
|
Muller JJ, Lapko A, Bourenkov G, Ruckpaul K, Heinemann U.
Adrenodoxin reductase-adrenodoxin complex structure suggests electron transfer path in steroid biosynthesis.
J. Biol. Chem. 276 2001 2786-9
[PubMed: 11053423]
http://dx.doi.org/10.1074/jbc.M008501200
|
|
Bossi RT, Aliverti A, Raimondi D, Fischer F, Zanetti G, Ferrari D, Tahallah N, Maier CS, Heck AJ, Rizzi M, Mattevi A.
A covalent modification of NADP+ revealed by the atomic resolution structure of FprA, a Mycobacterium tuberculosis oxidoreductase.
Biochemistry 41 2002 8807-18
[PubMed: 12102623]
http://dx.doi.org/10.1021/bi025858a
|
|
Pennati A, Razeto A, de Rosa M, Pandini V, Vanoni MA, Mattevi A, Coda A, Aliverti A, Zanetti G.
Role of the His57-Glu214 ionic couple located in the active site of Mycobacterium tuberculosis FprA.
Biochemistry 45 2006 8712-20
[PubMed: 16846214]
http://dx.doi.org/10.1021/bi060369m
|
|
Koch M, Breithaupt C, Kiefersauer R, Freigang J, Huber R, Messerschmidt A.
Crystal structure of protoporphyrinogen IX oxidase: a key enzyme in haem and chlorophyll biosynthesis.
EMBO J. 23 2004 1720-8
[PubMed: 15057273]
http://dx.doi.org/10.1038/sj.emboj.7600189
|
|
Dobritzsch D, Ricagno S, Schneider G, Schnackerz KD, Lindqvist Y.
Crystal structure of the productive ternary complex of dihydropyrimidine dehydrogenase with NADPH and 5-iodouracil. Implications for mechanism of inhibition and electron transfer.
J. Biol. Chem. 277 2002 13155-66
[PubMed: 11796730]
http://dx.doi.org/10.1074/jbc.M111877200
|
|
|
InterPro 23.1
|